Cases filed in the Third Circuit Courts
Cases 121 - 130 of 586
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ROBINETTE v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv01148
Plaintiff: MICHAEL J. ROBINETTE
Defendant: AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, ACETERIS, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
GALLAGHER v. HETERO DRUGS, LTD. et al
as 1:2022cv00930
Plaintiff: KELLY GALLAGHER
Defendant: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, HETERO DRUGS, LTD., HETERO LABS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GRUBB et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00918
Plaintiff: ESTATE OF DUDLEY WAYNE GRUBB and TERESA A. GRUBB
Defendant: AUROBINDO PHARMA, LTD., ARROW PHARMA (MALTA) LTD., AUROLIFE PHARMA, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
TIPPETT et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00826
Plaintiff: GARY LEE TIPPETT and ADELLA TIPPETT
Defendant: AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KNOTT et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00765
Plaintiff: PAYTON KNOTT and TERRI KNOTT
Defendant: AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAIS v. AUROBINDO PHARMA LTD. et al
as 1:2022cv00518
Plaintiff: RAYMOND DAIS
Defendant: AUROBINDO PHARMA LTD., MYLAN LABORATORIES LTD., MYLAN PHAMACEUTICALS INC. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
PALMER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00429
Plaintiff: LINDA PALMER
Defendant: AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMOOT v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00285
Plaintiff: LEE ESTHER SMOOT
Defendant: AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
EARNEST et al v. ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD. et al
as 1:2022cv00153
Plaintiff: DAVID EARNEST and BARBARA EARNEST
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?